Undruggable - A special 3-part Q&A series

Join us for a Q&A webinar event and explore Undruggable, a special edition podcast series produced by The Scientist’s Creative Services Team and brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines.

Beginning with the introduction of aspirin at the start of the 20th century, there have been three major waves of innovation in drug discovery. While breakthrough discoveries have been made, 85% of disease targets are still considered undruggable, which represents an ongoing barrier to discovering medicines for complex diseases like cancer and autoimmune conditions. Now, the fourth wave of innovation is here, led by new types of multispecific medicines that will radically alter our concept of how drugs can work and pave the way for new solutions.

  • Webinar 1 - Episodes 1 and 2, The Next Wave of Drug Development and Drugging the Undruggable: The Biology of PROTACs
    November 3, 2021 @ 2:30 PM ET
  • Webinar 2 - Episode 3, Discovery at the DNA Encoded Library
    November 10, 2021 @ 2:30 PM ET
  • Webinar 3 - Episode 4, The Emerging Induced Proximity Toolkit
    November 17, 2021 @ 2:00 PM ET
Visit this page to access the Undruggable podcast series!
  • Episode 1 - The Next Wave of Drug Development,
    October 21, 2021
  • Episode 2 - Drugging the Undruggable: The Biology of PROTACs,
    October 28, 2021
  • Episode 3 - Discovery at the DNA Encoded Library,
    November 4, 2021
  • Episode 4 - The Emerging Induced Proximity Toolkit,
    November 11, 2021
  • Episode 5 - Induced Proximity for Cancer and Beyond,
    November 18, 2021



Q&A Speakers

November 3, 2021
Rati Verma, PhD
Sr. Scientist
Discovery Research
November 10, 2021
Søren Jensby Nielsen, PhD
Scientific Director
Amgen Research Copenhagen
November 17, 2021
Margaret Chu-Moyer, PhD
Vice President
Research and Head of Chemistry, Characterization, and Technology (CCT)



Sign up for the series now

TS_Webinar_Amgen_Series 2_Undruggable_IO#403179

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.